TechConnect Innovation Program

Microfluidic hemoperfusion device for treatment of sepsis

Oregon State University, OR, United States

TECHNOLOGY SUMMARY

We have developed a platform technology that leverages high flow rate microfluidics and advanced surface coatings to enable safe and efficient removal of pathogenic entities from blood. As an initial application we are focusing on removal of endotoxin for treatment of sepsis.

Primary Application Area: Medical Devices

Technology Development Status: Concept

Technology Readiness Level: TRL 3

FIGURES OF MERIT

Value Proposition: Our technology will enable significantly improved adsorption efficiency and reduced damage to blood cells by leveraging microfabrication capabilities to precisely control the geometry of the blood flow path and by applying a coating to the device surface that imparts biocompatibility and improved capacity to bind endotoxin.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

National Innovation Awardee

Showcase Booth #: 501

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: NSF PFI: AIR-TT program, $200,000, July 2014-Dec. 2015

Primary Sources of Funding: Federal Grant, University

Looking for: Both Funding and Development Partners